Form 4: Amprius Technologies Executive Jonathan Bornstein Sells Shares

Jonathan Bornstein, President of Amprius Lab, sold a significant number of shares in Amprius Technologies over two days in November.

Summary

• Jonathan Bornstein, President of Amprius Lab, sold 133,536 shares of Amprius Technologies common stock on November 20, 2024, at an average price of $1.9237 per share.
• On November 21, 2024, Bornstein sold an additional 15,000 shares at an average price of $1.9624 per share.
• He also sold 18,170 shares on November 21, 2024, at an average price of $1.9646 per share to cover tax obligations related to vesting restricted stock units.
• The shares sold on November 20 and 21 were sold in multiple transactions at varying prices within the ranges of $1.89 to $1.98 and $1.92 to $2.02 respectively.
• Following these transactions, Bornstein directly owns 454,131 shares and indirectly owns 1,040,950 shares through the Jonathan G. Bornstein and Phyllis S. Brock Trust Agreement.

Sentiment

Score: 5

Explanation: The document is neutral in sentiment as it reports routine share sales by an executive. There is no indication of positive or negative news about the company's performance.

Negatives

• The sale of a significant number of shares by a company executive could be perceived negatively by the market.

Risks

• Executive share sales can sometimes signal a lack of confidence in the company's future prospects, potentially impacting investor sentiment.
• Large sales by insiders can create downward pressure on the stock price.

Industry Context

Executive share sales are a common occurrence, but the market often scrutinizes them for potential implications about a company's future performance. This is a routine filing for insider trading activity.

Comparison to Industry Standards

• Executive share sales are a normal part of corporate activity, and the size of these sales is not unusual for a company of Amprius's size.
• It is common for executives to sell shares to cover tax obligations related to vesting stock options or restricted stock units.
• The price ranges at which the shares were sold are within the typical trading range for the stock.

Stakeholder Impact

• Shareholders may react to the news of executive share sales, potentially leading to short-term price fluctuations.
• The sales do not directly impact employees, customers, or suppliers.

Key Dates

Keywords

Amprius Technologies, Jonathan Bornstein, share sale, insider trading, stock transaction, executive, AMPX